Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Bioinformatics challenges for genome-wide association studies.
Pediatric optic neuritis.
Female reproductive issues in multiple sclerosis.
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
Allelic combinations of immune-response genes as possible composite markers of IFN-β efficacy in multiple sclerosis patients.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Factors affecting anxiety in multiple sclerosis.
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis.
Ocular inflammation in neurorheumatic disease.
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis.
Immunosuppressive monoclonal antibodies: current and next generation.
Novel Immunomodulatory Approaches for the Management of Multiple Sclerosis.
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.
Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Regulation of ceramide synthase 6 in a spontaneous experimental autoimmune encephalomyelitis model is sex dependent.
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profiles.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
Brain-Derived Neurotrophic Factor in Neuroimmunology: Lessons Learned from Multiple Sclerosis Patients and Experimental Autoimmune Encephalomyelitis Models.
Vitamin D and multiple sclerosis: what is the clinical impact?
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
Pages
« first
‹ previous
…
251
252
253
254
255
256
257
258
259
…
next ›
last »